Innovation & Entrepreneurship -
Opportunities in Start-up and Midsize Companies
10:20-11:10
作為美國第三大生物科技聚落,南加州不只擁有知名的研究機構和製藥公司,還有許多新創公司。大型製藥公司擁有穩定性、完善的流程和豐富的資源,而新創企業提供了令人振奮的創新、自主權以及快速成長的潛力。對生技產業有興趣的你想要更了解大公司或新創的工作環境嗎?來聽聽業界專家的分享。 |
Dr. Randy Yang
Co-founder/CEO, Lucidity Medical |
Dr. Randy Yang is the Co-founder/CEO of Lucidity Medical – a medical device company dedicated to transforming clinical imaging with imaging physics and deep learning. Randy is an imaging innovator with a strong track record in developing and translating groundbreaking technologies for clinical use. He holds a Ph.D. in Biomedical Engineering from UCLA and a Bachelor's degree in EECS from National ChiaoTung University in Taiwan. With his rich academic background, Randy also hosts an NIH-funded imaging technology development laboratory at Cedars-Sinai Medical Center.
|
Dr. Sheng-Hsiou (Shawn) Hsu
Director of Data Science, Arctop Inc. |
Shawn Hsu is a developer and innovator in neurotech, biosensing, wearable technology, and digital health. He has been in two neurotech / wearable startups - currently as a Director of Data Science at Arctop, and previously a founding member / senior Research Scientist at NextSense. Prior to the startup adventures, he was a Research Scientist at Google X, the moonshot factory, and received a PhD in Bioengineering from UC San Diego.
|
Dr. Wen-Hsuan Chang
Head of Target Validation, AcuraStem |
As the head of AcuraStem’s Research Team, Wen-Hsuan Chang has worked with its founders to build the company from the ground up. Chang helped establish the core technology platform at AcuraStem, and now leads internal research projects and collaborations with external partners. Chang is responsible for therapeutic target validation, biomarker development, and monitoring pre-clinical studies. She received a B.S. in Chemical Engineering from National Tsing Hua University in Taiwan. Following one year of investigation into neurotransmitter release biology at Fu-Jen Catholic University, she entered graduate school and received her Ph.D. in Chemical Engineering from the University of Southern California. During her graduate work at USC, Chang identified a novel mechanism through which Wnt signaling controls the development of the mammalian cortex. After her Ph.D., Chang performed postdoctoral work in Dr. Justin Ichida’s laboratory at USC, where she identified key mechanisms by which the C9orf72 repeat expansion causes neurodegeneration in ALS and frontotemporal dementia. Chang also serves on the board of the Southern California Taiwanese Biotechnology Association. She has published multiple peer-reviewed scientific research papers in high-impact neuroscience, stem cell biology, and molecular biology journals.
|
Dr. Tom Lo
Associate Director in Molecular Imaging, RayzeBio |
Tom graduated from UT Southwestern Medical Center in PhD program of Radiological Sciences and trained as Radiochemist for development of Positron Emission Tomography imaging tracer. With 17+ years of experience in the design and execution of preclinical imaging studies to support drug development in various therapeutics, he moved to Johnson & Johnson to manage the biomarker imaging program and recently join San Diego-based startup company RayzeBio to lead the preclinical imaging program to support the targeted (alpha/beta) radiopharmaceutical development in varies oncology targets.
|
Moderators
Dennis Wu
Principal Scientist at Lynx Biosciences Dennis Wu is a scientist at Lynx Biosciences. He received a B.S. degree in Biochemistry and Cell Biology from the University of California, San Diego and received his Ph.D. in Immunology from UC Davis. As a scientist in Lynx Biosciences, he involves in research and development of imaging-based microfluidic technologies to study hematologic malignancies. Prior to joining Lynx Biosciences, Dennis focused his study on autoimmune diseases using various animal models and specialized in imaging techniques. Dennis actively participates in Southern California Taiwanese Biotechnology Association (SoCal TBA) since 2017 and designs the logo for SoCal TBA. |
Rose Chiang
Data Scientist at Akoya Biosciences Rose is a data scientist at Akoya Biosciences, where she focuses on building an analysis ecosystem for the latest biotechnologies. With a strong educational background, she holds a doctorate degree in Biomedical Engineering, a master's degree in Electrical Engineering with a focus on Machine Learning and Data Science, and a Certificate in Technology Commercialization from the University of Southern California. Before joining Akoya Biosciences, Rose successfully implemented her algorithms for commercial microscopy systems, including the Leica microscope. She also developed software for biologists to analyze complex data and led a team in commercializing hyperspectral imaging technology. Her dedication to developing cutting-edge analysis tools and software enables researchers to analyze and visualize biological data, with the ultimate goal of advancing medicine more precisely and accurately. |